When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University of California, Irvine neuroscientists has found news coverage of the FDA's decision made the public less willing to volunteer for Alzheimer's pharmaceutical trials.
Mumbai (Maharashtra) [India], March 31 (ANI/PR Newswire): Voltas, India's undisputed leader in Cooling Products, and the No. 1 AC brand, from the house of Tata's, has strengthened its leadership position further in the Cooling Products space, by launching India's First AC with HEPA Filter technology.
\
\
\
\
